In-Home Medication
portes grátis
In-Home Medication
Integrating Multidisciplinary Perspectives in Design-Driven Pharma Practices
Penati, Antonella Valeria
Springer International Publishing AG
01/2025
560
Dura
9783031532931
Pré-lançamento - envio 15 a 20 dias após a sua edição
Descrição não disponível.
1 Towards in-home medication: Medicinal products as daily objects.- Part 1 Objects of science: the pharmaceutical industry as a place of preciseness.- 2 Medicine packaging legislation and its evolution according to technological innovation for better healthcare support.- Addendum 1 - Regulatory references. - 3 Primary medicine packaging and quality control.- 4 Pharmaceutical forms and primary packaging: a glossary.- 5 Secondary packaging of medicines: design processes for the pharmaceutical industry.- 6 Secondary packaging and leaflets: a glossary.- Part 2 Prescribing and dispensing: accompanying the patient to the correct use of medicines.- 7 Moving the care process in the in-home context: the therapeutic prescription.- 8 Dispensing medicines: A necessary link between doctor and patient.- 9 The future digital pharmacological prescription between therapy adherence and integrated healthcare personal plans.- 10 Navigating the complexities of the OTC medicine ecosystem.- 11 Dealing with medicines through online platforms and communities.- Addendum 2 - Medication errors data.- Part 3 The daily life as a place of inaccuracy - the domesticity of therapy.- 12 Medicines as designed objects.- 13 The in-home place of medications: perspectives of domestication.- 14 In-home: Medicinals treatment as a learning process.- 15 Use phenomenologies. Observing the user while taking pharmaceutical therapies.- 16 Use phenomenologies. Oral solid forms in blister packs.- 17 Use phenomenologies. What does the user do with the secondary medicine packaging and package leaflet?.- Part 4 - The pharmaceutical product system: premises for the definition of a repertory of good practices.- 18 How political and cultural challenges are impacting pharma industries.- 19 Medicinal products: when innovation meets the patient.- 20 Pharmaceutical packaging according to the "Packaging Ethics Charter".- 21 Sensory qualities of the medicines: from problems to proposals.- 22 Compendium: step toward design-oriented practices in the pharma industry in a multidisciplinary perspective.- Addendum 3 The name of medicines. LASA medicines.- Addendum 4 - Methods of user involvement.- Addendum 5 - Error Reporting Procedures.
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
Medicines and person-centered design;Patient and caregiver in at-home therapies;Medicine Packaging, package leaflet and devices;Medicine and integrated individualized plan;Gender medicine in drug development;Social networks in medicines' communication;Design and pharmaceutical products;Medicines as "technical object" and "daily object";Medicines in domestic context and user behavior;Pharma industry and user-centered innovations;Law and innovation in Pharma industry;Design communication for accessibility to therapies;Guidelines for improving medicine usability;Patient engagement in drug development;Medicines and primary and secondary packaging quality;Therapy adherence and medicines prescription;Electronic prescriptions;Sensory qualities of the medicines;Ethics Charter of medicine packaging;Open Access
1 Towards in-home medication: Medicinal products as daily objects.- Part 1 Objects of science: the pharmaceutical industry as a place of preciseness.- 2 Medicine packaging legislation and its evolution according to technological innovation for better healthcare support.- Addendum 1 - Regulatory references. - 3 Primary medicine packaging and quality control.- 4 Pharmaceutical forms and primary packaging: a glossary.- 5 Secondary packaging of medicines: design processes for the pharmaceutical industry.- 6 Secondary packaging and leaflets: a glossary.- Part 2 Prescribing and dispensing: accompanying the patient to the correct use of medicines.- 7 Moving the care process in the in-home context: the therapeutic prescription.- 8 Dispensing medicines: A necessary link between doctor and patient.- 9 The future digital pharmacological prescription between therapy adherence and integrated healthcare personal plans.- 10 Navigating the complexities of the OTC medicine ecosystem.- 11 Dealing with medicines through online platforms and communities.- Addendum 2 - Medication errors data.- Part 3 The daily life as a place of inaccuracy - the domesticity of therapy.- 12 Medicines as designed objects.- 13 The in-home place of medications: perspectives of domestication.- 14 In-home: Medicinals treatment as a learning process.- 15 Use phenomenologies. Observing the user while taking pharmaceutical therapies.- 16 Use phenomenologies. Oral solid forms in blister packs.- 17 Use phenomenologies. What does the user do with the secondary medicine packaging and package leaflet?.- Part 4 - The pharmaceutical product system: premises for the definition of a repertory of good practices.- 18 How political and cultural challenges are impacting pharma industries.- 19 Medicinal products: when innovation meets the patient.- 20 Pharmaceutical packaging according to the "Packaging Ethics Charter".- 21 Sensory qualities of the medicines: from problems to proposals.- 22 Compendium: step toward design-oriented practices in the pharma industry in a multidisciplinary perspective.- Addendum 3 The name of medicines. LASA medicines.- Addendum 4 - Methods of user involvement.- Addendum 5 - Error Reporting Procedures.
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
Medicines and person-centered design;Patient and caregiver in at-home therapies;Medicine Packaging, package leaflet and devices;Medicine and integrated individualized plan;Gender medicine in drug development;Social networks in medicines' communication;Design and pharmaceutical products;Medicines as "technical object" and "daily object";Medicines in domestic context and user behavior;Pharma industry and user-centered innovations;Law and innovation in Pharma industry;Design communication for accessibility to therapies;Guidelines for improving medicine usability;Patient engagement in drug development;Medicines and primary and secondary packaging quality;Therapy adherence and medicines prescription;Electronic prescriptions;Sensory qualities of the medicines;Ethics Charter of medicine packaging;Open Access
